|
A.I. Sinopalnikov
Antibiotics and community-acquired low respiratory tract infections. Who for? What preparation?
|
№5 / 2019
|
|
Yu.G. Belotserkovskaya, A.I. Sinopalnikov, A.G. Romanovskikh, I.P. Smirnov
The concept of controlling chronic obstructive pulmonary disease
|
№5 / 2019
|
|
A.V. Emelyanov, E.V. Leshenkova, G.R. Sergeeva
Inhaled glucocorticosteroids in the treatment of chronic obstructive pulmonary disease: the debate continues
|
№5 / 2019
|
|
A.A. Vizel, I.Yu. Vizel, I.N. Salakhova, A.R. Vafina
TRIPLE THERAPY FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: FROM ANALYSIS TO PRACTICE
|
№14 / 2017
|
|
I.N. Trofimenko, B.A. Chernyak
CLINICAL AND FUNCTIONAL FEATURES AND BRONCHOPROTECTIVE EFFECT OF M-CHOLINOLITHICS IN PATIENTS WITH COPD WITH BRONCHIAL HYPERREACTIVITY
|
№14 / 2017
|
|
A.F. Verbovoy (1), I.A. Tsanava (1), N.I. Verbovaya (1), R.A. Galkin (1), I.V. Madyanov (2)
POLYMORBIDITY AND MODERN MEDICINE
|
№16 / 2017
|
|
V.N. Shishkova
PROBLEMS OF COMORBID PATIENT AND POLYPRAGMASY IN NEUROLOGY
|
№9 / 2017
|
|
I.N. Trofimenko, B.A. Chernyak
CLINICAL CHARACTERISTICS OF EOSINOPHILIC PHENOTYPE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
|
№4 / 2017
|
|
A.A. Zaitsev
RATIONAL ANTIMICROBIAL THERAPY FOR THE TREATMENT OF EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
|
№14 / 2016
|
|
E.A.Ushkalova
SUPPORTING TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
|
№4 / 2016
|
|
I.E. Zhila, O.V. Galkina, E.O. Bogdanova, N.L. Shaporova, O.V. Dudina
OSTEOPOROSIS IN PATIENTS WITH BRONCHO-OBSTRUCTIVE PATHOLOGY
|
№s4-15 / 2015
|
|
E.P .Terekhova, D.V. Terekhov
PULMONARY DRUG DELIVERY SYSTEM FOR DRUGS USED IN THE TREATMENT OF OBSTRUCTIVE PULMONARY DISEASES
|
№s1-15 / 2015
|
Русский
